drugset / Trial / NCT02474134
Comparison Study of PF530 and Betaferon in Healthy Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to compare the safety, tolerability, and blood levels of two interferon beta-1b products, Betaferon and PF530, in healthy volunteers.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon beta-1b | Protein / enzyme biologic | 0.25 mg | Subcutaneous |
| Subject | PF530 | Unknown | 0.25 mg | Subcutaneous |